What question did this study set out to answer?

To examine the pathogenic contribution of mitochondrial DNA mutations and deletions to mitochondrial dysfunction in Parkinson's disease, focusing on the cross-talk between mitochondrial and nuclear genomes.

December 10, 2020BiomedicinesOpen Access

Mitochondrial Dysfunction in Parkinson’s Disease: Focus on Mitochondrial DNA

View Full Paper

Ask AI

Bookmark

Authors

ОБО.А. БунееваInstitute of Biomedical Chemistry VFV.I. FedchenkoInstitute of Biomedical Chemistry AKArthur T. KopylovLomonosov Moscow State University

Discussion

Member takes

Implication

Review uncovers mitochondrial DNA mutations and genome cross-talk in Parkinson’s disease models, highlighting nuclear suppression mechanisms in cellular maintenance.

Key Points

To examine the pathogenic contribution of mitochondrial DNA mutations and deletions to mitochondrial dysfunction in Parkinson's disease, focusing on the cross-talk between mitochondrial and nuclear genomes.
Synthesized findings from cellular models derived from Parkinson's disease patients, including cytoplasmic hybrids (cybrids).
Evaluated genetic and phenotypic data from mtDNA mutator mouse models displaying replication errors mediated by nuclear factors like polymerase γ.
Reviewed proteomic profiling data assessing mitochondrial protein expression across multiple experimental Parkinson's disease models.
Elevated mtDNA mutation rates occur due to physical proximity to reactive oxygen species generated by the inner mitochondrial membrane's oxidative phosphorylation system, associating with increased Parkinson's disease risk.
Abnormalities in nuclear-encoded replication machinery, including polymerase γ, drive pathogenic mtDNA deletions that compromise dopaminergic neuronal integrity in the substantia nigra.
Proteomic analyses identify down-regulation of only a minimal subset of mtDNA-encoded proteins across disease models, indicating nuclear genome-mediated suppression and compensatory maintenance of mitochondrial function.

Cite This Study

Бунеева et al. (2020) studied this question.

synapsesocial.com/papers/6a9677d67c15eaca02577d88 https://doi.org/10.3390/biomedicines8120591

View Full Paper

Ask AI

Bookmark

Implication

Review uncovers mitochondrial DNA mutations and genome cross-talk in Parkinson’s disease models, highlighting nuclear suppression mechanisms in cellular maintenance.

Mitochondrial Dysfunction in Parkinson’s Disease: Focus on Mitochondrial DNA

Discussion

Member takes

Implication

Key Points

Cite This Study

Mitochondrial Dysfunction in Parkinson’s Disease: Focus on Mitochondrial DNA

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider